Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that a detailed analysis of the Phase III ALLEGORY trial of Gazyva ® (obinutuzumab) in adults with systemic lupus ...
Study shows testosterone therapy does not increase anger, irritability, or aggression in trans youth
The study, published this week in the Journal of Adolescent Health, addresses a common concern by trans youth and their ...
In 2025, something unexpected happened. The programming language most notorious for its difficulty became the go-to choice ...
Ahead of International Women’s Day, new claims data from Healix Health highlights significant gender differences in health conditions and claims patterns. For ...
Jodie Gallagher, Head of UK IFA Products at FE fundinfo, looks at how AI is being used to strengthen the operational backbone ...
Dunfermline Athletic ease past beleaguered Aberdeen to advance to their first Scottish Cup semi-final since 2009 with a dominant victory at East End Park.
Scientists in China have managed to hatch a butterfly in space for the first time. Researchers at Chongqing University confirmed a butterfly successfully emerged from its chrysalis - a hard protective ...
The upstate New York firm makes precision components for data centers and semiconductor plants. It's bringing 230 jobs to the ...
Hello Sunshine, the Reese Witherspoon-founded media brand, recently launched a next-gen subset of its popular book club aimed ...
Friday’s U.S. non-farm payrolls and unemployment figures for February will bring those concerns to the forefront ...
Louder for the people in the back ...
Brelovitug is being developed for HDV, the most severe form of viral hepatitis, and a disease with no approved therapies in the U.S. HDV occurs in people already infected with hepatitis B virus (HBV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results